- Stock: IN STOCK
- Brand: DEUS MEDICAL
- Reward Points: RECEIVE 7 REWARD POINTS
- Model: WINIMED 50
- Review count: 23 , Add testimonial
- Average rating: 5
WINIMED 50 – Injectable Stanozolol
PRODUCT OVERVIEW
WINIMED 50 provides Stanozolol in an injectable steroid that is widely acknowledged as a primary anabolic for those focusing on specific performance outcomes. It is delivered at a concentration of 50mg/ml for intramuscular application according to established protocol guidelines. By offering this compound in a standardised injectable form, the product supports users who prioritise consistency and transparency in their preparation routines. All while following a structured programme that incorporates Stanozolol as a fundamental component of their systemic energy and physique management.
This specific concentration allows for consistent integration into performance protocols where users require a reliable and standardised format. This helps support their established training objectives and physique refinement goals throughout the duration of a structured cycle. It is typically selected in cutting phases where users want to minimise water and fat retention within a structured programme. This product is intended for experienced users who are already familiar with injectable anabolic steroids. When incorporating Stanozolol as part of a broader performance or physique-focused plan, following a defined protocol is of great import.
KEY FEATURES
- Active Ingredient: Stanozolol
- Form: Injectable anabolic steroid (oil/suspension, intramuscular use)
- Concentration: 50mg/ml
- Brand: Deus Medical
- Category: Anabolic steroid, commonly used in cutting phases
- Package Content: 1 box of 10 ampoules, 1ml (1 cc) per ampoule
- Also Known As: Winstrol, Winny, Androstanazol, Androstanazole, Stanazol, Stromba
BENEFITS
- Physique Management Support: WINIMED 50 is generally chosen in cutting or recomposition phases where the management of water and fat retention is a key consideration within a planned cycle and this allows for a more refined approach to physique management.
- Aesthetic Protocol Integration: Its injectable format allows users already familiar with Stanozolol to integrate it into protocols that emphasise appearance and hardness and tighter weight management rather than bulk-oriented mass gain which is essential for achieving specific aesthetic goals.
- Consistent Dosing Precision: The fixed 50mg/ml concentration and ampoule-based packaging provide a consistent unit of measure which can support structured dosing plans established by experienced users to ensure that every administration remains precise and aligned with the intended performance protocol.
USAGE INSTRUCTIONS
- Standard Dosing Protocol: The dosing of WINIMED 50 (Stanozolol) ranges around 50–100mg administered every other day which equates to approximately 200–400mg per week within a standard protocol and the injectable form is often preferred when longer cycle durations are planned as it is generally considered more suitable for extended use than the oral format.
- Cycle Duration Guidelines: It is important to recognise that due to differences in hepatotoxicity between oral and injectable Stanozolol users run injectable WINIMED 50 cycles for about 8–10 weeks while oral Stanozolol cycles are usually shorter at around 6–8 weeks respectively.
- Integration and Planning: Any use should remain within these established time frames and be integrated into a broader well-structured cycle plan that accounts for individual tolerance and experience level as well as the overall stack composition to ensure that the metabolic and performance goals of the programme are met effectively.
IMPORTANT INFORMATION
- Advanced User Requirements: WINIMED 50 is a potent anabolic steroid and is not intended for beginners or unsupervised use and it should only be used by individuals who understand the demands and risks and monitoring requirements associated with injectable anabolic compounds.
- Protocol Duration Limits: Users must avoid exceeding established dosage ranges or extending cycle length beyond typical 8–10 week injectable protocols to ensure that the metabolic and hormonal foundation of the cycle remains stable throughout the duration of the programme.
- Structured Integration Standards: WINIMED 50 should not be combined with other compounds or dosages outside of a structured plan and any integration into a stack should be deliberate and well-coordinated to ensure that the hormonal balance of the cycle remains within established performance parameters.
- Specific Usage Contraindications: This product is strictly contraindicated for women who are pregnant or planning to become pregnant due to the significant risk of virilisation and developmental complications and it is not suitable for individuals with known sensitivities to Stanozolol or any component of the formulation.
- Regulatory Compliance Awareness: Users must remain aware of all applicable regulations in their jurisdiction before purchase or use to ensure full compliance with local legal standards and to maintain the highest level of professional responsibility during the execution of their performance protocol.
STORAGE
- Store below 30°C.
- Keep away from direct sunlight.
- Do not freeze.
- Keep out of reach of children.
LEGAL DISCLAIMER
This product is intended for use only in accordance with applicable laws and regulations. The information provided is for educational purposes and does not replace medical advice. Misuse may involve health risks. Seek professional guidance where appropriate.
WHY CHOOSE OUR WINIMED 50 STANOZOLOL 50MG/ML?
- Precise Ampoule Format: Our WINIMED 50 Stanozolol 50mg/ml is presented in a clear 1ml ampoule format to support precise and repeatable administration within cutting or refinement cycles where consistent dosing is a priority.
- Defined Concentration for Protocol Planning: Each ampoule contains a defined 50mg/ml concentration which helps experienced users structure their weekly totals in line with established 50–100mg every-other-day protocols.
- Transparent Packaging and Documentation: Deus Medical is recognised for its commitment to consistent production standards and professional presentation. Packaging and labelling are designed to clearly communicate concentration and volume and storage conditions to offer a transparent and organised option for those integrating injectable Stanozolol into a broader protocol-driven performance stack.
FAQ